Cargando…

Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis

BACKGROUND: To use competing analyses to estimate the prognostic value of KRAS mutation status in colorectal cancer (CRC) patients and to build nomogram for CRC patients who had KRAS testing. METHOD: The cohort was selected from the Surveillance, Epidemiology, and End Results database. Cumulative in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Dongjun, Wang, Yanmei, Zhu, Liyuan, Jin, Hongchuan, Wang, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271887/ https://www.ncbi.nlm.nih.gov/pubmed/32547859 http://dx.doi.org/10.7717/peerj.9149

Ejemplares similares

Prognostic analysis of very early onset pancreatic cancer: a population-based analysis
por: Dai, Dongjun, et al.
Publicado: (2020)

Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis
por: Dai, Dongjun, et al.
Publicado: (2019)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma
por: Dai, Dongjun, et al.
Publicado: (2020)

Prognostic Value of Autophagy, Microsatellite Instability, and KRAS Mutations in Colorectal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study
por: Allemani, C, et al.
Publicado: (2004)

N6-methyladenosine links RNA metabolism to cancer progression
por: Dai, Dongjun, et al.
Publicado: (2018)

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020)

Impact of primary colorectal Cancer location on the KRAS status and its prognostic value
por: Xie, Ming-zhi, et al.
Publicado: (2019)

Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
por: Guo, Tianan, et al.
Publicado: (2021)

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
por: Popovici, Vlad, et al.
Publicado: (2013)

The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study
por: Dai, Dongjun, et al.
Publicado: (2019)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017)

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
por: Lavacchi, Daniele, et al.
Publicado: (2022)

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
por: Li, S, et al.
Publicado: (2014)

Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
por: Guo, Fang, et al.
Publicado: (2018)

Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma
por: Dai, Dongjun, et al.
Publicado: (2020)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
por: Díez-Alonso, Manuel, et al.
Publicado: (2021)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer
por: Xu, Jun, et al.
Publicado: (2021)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population
por: Chen, Ruixian, et al.
Publicado: (2022)

Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report
por: El agy, Fatima, et al.
Publicado: (2021)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
por: Palomba, Grazia, et al.
Publicado: (2016)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
por: Shemirani, Atena Irani, et al.
Publicado: (2011)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer
por: Song, Ping, et al.
Publicado: (2020)

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
por: Yokota, Tomoya
Publicado: (2012)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

Prognostic significance of KRAS gene mutations in colorectal cancer - preliminary study
por: Dinu, D, et al.
Publicado: (2014)

Histology and its prognostic effect on KRAS-mutated colorectal carcinomas in Korea
por: Lee, Hye Seung, et al.
Publicado: (2020)

Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
por: Wang, Chengfeng, et al.
Publicado: (2022)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
por: Radanova, Maria, et al.
Publicado: (2023)

Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2023)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
por: Lohinai, Zoltan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iopu6clctega0n63jndrb50bac